Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell

@article{Inamdar2013MesenchymalSC,
  title={Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell},
  author={A. C. Inamdar and A. Inamdar},
  journal={Experimental Lung Research},
  year={2013},
  volume={39},
  pages={315 - 327}
}
  • A. C. Inamdar, A. Inamdar
  • Published 2013
  • Medicine
  • Experimental Lung Research
  • ABSTRACT Lung disorders such as asthma, acute respiratory distress syndrome (ARDS), chronic obstructive lung disease (COPD), and interstitial lung disease (ILD) show a few common threads of pathogenic mechanisms: inflammation, aberrant immune activity, infection, and fibrosis. Currently no modes of effective treatment are available for ILD or emphysema. Being anti-inflammatory, immunomodulatory, and regenerative in nature, the administration of mesenchymal stem cells (MSCs) has shown the… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Pulmonary Disorders are often categorized as Obstructive or Restrictive disorders. This study will establish two channels of investigation, one group within each type of pulmonary… Expand
    ConditionsCOPD, Respiratory Insufficiency
    InterventionProcedure
    INTERVENTIONAL CLINICAL TRIAL
    Chronic Obstructive Pulmonary Disease (COPD) is a lung-related disorder that is characterized by long-term, often progressive state of poor airflow. Primary symptoms include low oxygen… Expand
    ConditionsLung Disease
    InterventionProcedure
    INTERVENTIONAL CLINICAL TRIAL
    This study is being done to test if it is safe to give stem cells to adult patients with Cystic Fibrosis (CF). The kind of stem cells we are studying are called allogeneic human… Expand
    ConditionsCystic Fibrosis
    InterventionBiological
    Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
    • 32
    • PDF
    The clinical use of regenerative therapy in COPD
    • 3
    • PDF
    Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
    • 88

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 131 REFERENCES
    Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors
    • 87